| ISIN | LU2317078678 |
|---|---|
| Valor Number | 110465488 |
| Bloomberg Global ID | |
| Fund Name | Pictet - Quest Europe Sustainable Equities HZ CHF |
| Fund Provider |
Pictet Asset Management S.A.
Genève, Switzerland Phone: +41 58 323 10 24 www.assetmanagement.pictet |
| Fund Provider | Pictet Asset Management S.A. |
| Representative in Switzerland |
Pictet Asset Management S.A. Genève 73 Phone: +41 58 323 30 00 |
| Distributor(s) |
Credit Suisse AG Zürich Phone: +41 44 333 11 11 UBS AG Zürich Phone: +41 44 234 11 11 Vontobel Fonds Services AG Zürich Phone: +41 58 283 74 77 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
| Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
| Investment Strategy *** | The investment objective of the fund is to increase the value of investment. The Fund invests at least two-thirds of its net assets in equities issued by companies that are headquartered in and/or conduct their main business in Europe. The portfolio is constructed using a quantitative method that selects companies according to their financial stability with the objective to build a portfolio with superior financial and sustainable characteristics. |
| Peculiarities |
| Current Price * | 555.15 CHF | 31.10.2025 |
|---|---|---|
| Previous Price * | 557.73 CHF | 30.10.2025 |
| 52 Week High * | 562.06 CHF | 27.10.2025 |
| 52 Week Low * | 480.81 CHF | 09.04.2025 |
| NAV * | 555.15 CHF | 31.10.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 1,099,244,430 | |
| Unit/Share Assets *** | 27,159 | |
| Trading Information SIX | ||
| YTD Performance | +7.93% |
31.12.2024 - 31.10.2025
31.12.2024 31.10.2025 |
|---|---|---|
| 1 month | +2.20% |
30.09.2025 - 31.10.2025
30.09.2025 31.10.2025 |
| 3 months | +2.03% |
31.07.2025 - 31.10.2025
31.07.2025 31.10.2025 |
| 6 months | +4.35% |
30.04.2025 - 31.10.2025
30.04.2025 31.10.2025 |
| 1 year | +10.25% |
31.10.2024 - 31.10.2025
31.10.2024 31.10.2025 |
| 2 years | +28.64% |
31.10.2023 - 31.10.2025
31.10.2023 31.10.2025 |
| 3 years | +39.30% |
31.10.2022 - 31.10.2025
31.10.2022 31.10.2025 |
| 5 years | +29.65% |
14.06.2021 - 31.10.2025
14.06.2021 31.10.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HSBC Holdings PLC | 4.14% | |
|---|---|---|
| Novartis AG Registered Shares | 4.13% | |
| Banco Bilbao Vizcaya Argentaria SA | 3.11% | |
| Zurich Insurance Group AG | 3.04% | |
| Sanofi SA | 2.99% | |
| AstraZeneca PLC | 2.96% | |
| L'Oreal SA | 2.92% | |
| AXA SA | 2.83% | |
| RELX PLC | 2.82% | |
| GSK PLC | 2.71% | |
| Last data update | 30.09.2025 | |
| TER *** | 0.13% |
|---|---|
| TER date *** | 31.03.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.00% |
| Ongoing Charges *** | 0.13% |
|
SRRI ***
|
|
| SRRI date *** | 31.07.2021 |